Core Viewpoint - DIRTT Environmental Solutions Ltd. has announced the renewal of its normal course issuer bid (NCIB) for its convertible unsecured subordinated debentures, allowing the company to repurchase a specified amount of its debentures under certain conditions [1][2]. Group 1: NCIB Details - The renewed NCIB will allow DIRTT to acquire up to C$1,656,900 principal amount of January Debentures and C$1,493,500 principal amount of December Debentures, representing 10% of the total public float of each series [2]. - The NCIB for the December Debentures is set to terminate on August 27, 2026, while the NCIB for the January Debentures will terminate on January 31, 2026 [1]. - DIRTT will not purchase more than C$99,092 principal amount of January Debentures or C$350,552 principal amount of December Debentures on any given trading day [2]. Group 2: Previous NCIB Performance - Under the previous 2024 NCIB, DIRTT sought approval to purchase C$1,664,200 principal amount of January Debentures and C$1,558,700 principal amount of December Debentures, having purchased C$73,000 and C$652,000 of each, respectively [3]. Group 3: Repurchase Plans - DIRTT plans to enter into an issuer repurchase plan agreement (IRPA) and an automatic repurchase plan agreement (ARPP) to facilitate purchases under the NCIB [4]. - The ARPP will allow DIRTT to make purchases during regulatory restrictions or blackout periods, with the designated broker determining the timing and amount of such purchases [4]. Group 4: Company Overview - DIRTT is a leader in industrialized construction, providing a system of physical products and digital tools for adaptable interior environments across various sectors including workplace, healthcare, and education [5][6].

Core Viewpoint - Inter-Rock Minerals Inc. has announced a normal course issuer bid (NCIB) to purchase up to 1,000,000 common shares, representing approximately 4.6% of its outstanding shares, to enhance shareholder value and liquidity [1][4]. Group 1: NCIB Details - The NCIB will commence on or about August 29, 2025, and will last for twelve months, terminating upon the purchase of 1,000,000 shares, a notice of termination, or on August 28, 2026, whichever comes first [2]. - Purchases will be conducted on the open market through the TSX Venture Exchange or other permitted trading systems, with all shares purchased being cancelled [3]. - The funding for the NCIB will come from the company's working capital, and the actual number of shares purchased will be at the discretion of the board of directors [3]. Group 2: Rationale for NCIB - The company believes that its share price does not reflect its underlying value and future prospects, making the share buyback an appropriate use of financial resources [4]. - By purchasing shares at prices below their underlying value, the NCIB aims to increase the ownership proportion for remaining shareholders and provide liquidity for those wishing to sell [4]. Group 3: Previous NCIB Performance - The previous NCIB, which ran from August 21, 2024, to August 20, 2025, resulted in the purchase of 228,000 common shares at an average price of $0.81 per share [6].

Core Viewpoint - Senvest Capital Inc. has announced its intention to initiate a normal course issuer bid (NCIB) to repurchase up to 100,000 common shares, representing approximately 4.12% of its outstanding shares, to enhance market stability and utilize corporate funds effectively [1][3]. Group 1: NCIB Details - The NCIB will allow the Corporation to purchase shares through the TSX and other trading systems, with purchases expected to start on August 27, 2025, and conclude by August 26, 2026, or when the purchases are completed [1]. - Due to low trading volumes, actual purchases may be significantly less than the proposed 100,000 shares, with an average daily trading volume of only 45 shares over the past six months [2]. - The Corporation can purchase up to 1,000 shares on any trading day and make block purchases no more than once per week [2]. Group 2: Management's Perspective - Management believes that repurchasing shares may facilitate an orderly market for its securities and is in the best interests of the Corporation and its shareholders [3]. - The Corporation views its outstanding common shares as an attractive investment opportunity and a prudent use of corporate funds [3]. Group 3: Automatic Purchase Plan - An automatic purchase plan has been established to guide share repurchases during self-imposed blackout periods, complying with Canadian securities legislation and pre-cleared by the TSX [4]. Group 4: Previous NCIB Performance - In the previous NCIB that commenced on August 22, 2024, the Corporation purchased and canceled a total of 16,500 shares at an average price of $358.87 per share through the TSX and 1,200 shares at an average price of $354.06 outside the TSX [5]. Group 5: Business Activities - Senvest Capital Inc. and its subsidiaries are involved in various business activities, including merchant banking, asset management, real estate, and electronic security [6].

Core Viewpoint - Knight Therapeutics Inc. has announced the acceptance of its Notice of Intention to Make a Normal Course Issuer Bid (NCIB) to repurchase up to 3,000,000 common shares, representing approximately 3% of its outstanding shares, over the next 12 months [1][3] Group 1: NCIB Details - The NCIB allows the company to purchase shares from August 22, 2025, to August 21, 2026, with a maximum daily purchase limit of 15,823 shares [1] - The company previously obtained approval to buy up to 5,312,846 shares and has already repurchased 2,019,906 shares at a weighted average price of $5.48 in the past twelve months [1] Group 2: Automatic Share Purchase Plan - Knight has entered into an automatic share purchase plan with a broker to facilitate share repurchases under the NCIB, allowing purchases during regulatory restrictions or blackout periods [2] - The plan has been pre-cleared by the TSX and will be effective from August 22, 2025 [2] Group 3: Company Perspective - The company believes that the market price of its common shares may not reflect its inherent value, making the share repurchase an appropriate use of funds [3] Group 4: Company Overview - Knight Therapeutics Inc. is a specialty pharmaceutical company based in Montreal, focused on acquiring and commercializing pharmaceutical products for Canada and Latin America [4] - The company's shares are traded on the TSX under the symbol GUD [4]

Core Viewpoint - Brookfield Corporation has received approval from the Toronto Stock Exchange for the renewal of its normal course issuer bid to repurchase up to 10% of the public float of its outstanding Class A Preference Shares, with the bid period extending from August 22, 2025, to August 21, 2026 [1][3]. Summary by Relevant Sections Normal Course Issuer Bid - The renewed normal course issuer bid allows Brookfield to purchase Preferred Shares on the open market, with all acquired shares to be cancelled [1][3]. - The company has not made any purchases under the current issuer bid that commenced on August 22, 2024, which will expire on August 21, 2025 [3]. Series and Trading Information - The company has various series of Preferred Shares, with the maximum number of shares subject to purchase varying by series. For example, Series 2 has a maximum of 1,717 shares, while Series 24 has a maximum of 2,966 shares [2][14]. - The average daily trading volume for these shares ranges from 1,000 to 11,864, depending on the series [2]. Automatic Share Purchase Plan - Brookfield plans to implement an automatic share purchase plan around the week of September 22, 2025, allowing for purchases during internal trading black-out periods [4]. Company Overview - Brookfield Corporation is a leading global investment firm focused on long-term wealth creation across three core businesses: Alternative Asset Management, Wealth Solutions, and Operating Businesses in renewable power, infrastructure, and real estate [6][7]. - The company has a history of delivering over 15% annualized returns to shareholders for more than 30 years, supported by its investment and operational expertise [7].

Core Viewpoint - Brookfield Business Partners intends to renew its normal course issuer bid for its limited partnership units and class A exchangeable subordinate voting shares, believing that their current trading prices do not fully reflect their value, making repurchase an attractive use of funds [1][2]. Summary by Sections Issuer Bid Details - The Toronto Stock Exchange has accepted Brookfield Business Partners' notice to renew its normal course issuer bid for its Units and Exchangeable Shares [1]. - As of August 8, 2025, there are 88,828,512 Units and 69,996,738 Exchangeable Shares outstanding [2]. - Brookfield Business Partners is authorized to purchase up to 4,441,425 Units and 3,499,836 Exchangeable Shares, which is 5% of the outstanding shares [2]. Purchase Limits and History - Under the current issuer bid, Brookfield may purchase up to 10,076 Units and 11,100 Exchangeable Shares daily, representing 25% of the average daily trading volume over the past six months [2]. - The previous issuer bid, which expires on August 18, 2025, allowed for the purchase of up to 3,714,088 Units, with 3,611,689 Units purchased at a weighted average price of US$22.54 as of August 8, 2025 [4]. - For the Exchangeable Shares, 2,957,523 were purchased under the previous bid at a weighted average price of US$25.93 [5]. Purchase Execution and Compliance - Purchases will be conducted through the TSX, NYSE, and alternative trading systems, with all acquired Units and Exchangeable Shares being cancelled [6]. - The company has established automatic repurchase plans to facilitate purchases during internal trading black-out periods, with the actual number and timing of purchases dependent on market conditions [7]. Company Overview - Brookfield Business Partners is a global business services and industrials company focused on owning and operating high-quality businesses that provide essential products and services [8]. - It is the flagship listed vehicle of Brookfield Asset Management's Private Equity Group, which manages over $1 trillion in assets [9].

Core Viewpoint - Eldorado Gold Corporation has received approval to renew its normal course issuer bid (NCIB) to repurchase up to 10,159,967 common shares, representing 5% of its outstanding shares, as a strategy to enhance shareholder returns and reflect the long-term value of its shares [1][2][6]. Summary by Sections NCIB Details - The NCIB will allow Eldorado to purchase up to 10,159,967 common shares, commencing on August 6, 2025, and ending on July 31, 2026 [2]. - Daily purchases on the TSX will be limited to 101,895 common shares, based on the average daily trading volume [4]. - The previous NCIB, which ran from November 8, 2024, to July 31, 2025, resulted in the purchase of 3,198,353 common shares at an average price of C$27.68 [3]. Share Repurchase Plan - Up to 9,679,967 common shares repurchased will be cancelled, while 480,000 shares will be held in trust for the restricted share unit plan [5]. - An automatic repurchase plan has been established to facilitate share purchases during regulatory black-out periods [7]. Rationale for NCIB - The renewal of the NCIB is based on the belief that the market price of the common shares may not fully reflect their long-term value, making the repurchase an attractive use of available funds [6]. - The company emphasizes its strong balance sheet and ongoing cash generation in a favorable gold price environment as reasons for the NCIB [6]. Company Overview - Eldorado Gold is a producer of gold and base metals with operations in Türkiye, Canada, and Greece, and is committed to responsible operations and enhancing shareholder value [9].

Under its current NCIB, which entered into effect on August 2, 2024 and which expires on August 1, 2025, Globex is authorized to purchase up to 1,000,000 shares. Under the NCIB, Globex has repurchased a total of 169,200 common shares at a volume weighted average purchase price of $0.8971 per share, through the facilities of the TSX and on alternative trading systems in Canada. All of the repurchased shares were cancelled by Globex. ROUYN-NORANDA, Québec, July 28, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTER ...

Core Viewpoint - Extendicare Inc. has received approval from the Toronto Stock Exchange for the renewal of its normal course issuer bid, allowing the company to repurchase up to 7,281,193 common shares, which is 10% of its public float [1][4] Group 1: NCIB Details - The NCIB will commence on July 2, 2025, and will continue until July 1, 2026, or until the bid is completed [2] - Daily purchases under the NCIB will be limited to 44,803 common shares based on the average daily trading volume of 179,213 shares over the last six months [2] - All common shares purchased under the NCIB will be cancelled [3] Group 2: Rationale and Strategy - The board of directors believes that purchasing common shares may be an attractive use of corporate funds based on market conditions and share price [4] - The company has not purchased any shares under its previous NCIB, which allowed for the purchase of up to 7,159,997 common shares [5] Group 3: Automatic Purchase Plan - Extendicare has established an automatic purchase plan with its designated broker to facilitate share purchases during regulatory black-out periods [6] Group 4: Company Overview - Extendicare is a leading provider of care and services for seniors in Canada, operating 99 long-term care homes and delivering approximately 11.2 million hours of home health care services annually [7] - The company employs around 26,500 qualified team members dedicated to providing high-quality care [7]

Core Viewpoint - High Arctic Overseas Holdings Corp. intends to initiate a Normal Course Issuer Bid to repurchase up to 622,408 Common Shares, representing approximately 5% of the total shares outstanding, over a 12-month period from June 20, 2025, to June 19, 2026 [2][4]. Group 1 - The Corporation plans to purchase shares at the prevailing market price, with the actual number and timing of purchases determined by management [2][3]. - Purchases will be conducted on the open market and will be financed from the Corporation's working capital [3]. - The Board of Directors believes the current market price does not reflect the underlying value of the Corporation, making the share repurchase an appropriate use of corporate funds [4]. Group 2 - High Arctic Overseas is a market leader in Papua New Guinea, providing drilling and specialized well completion services, as well as equipment rental solutions [6].